231 related articles for article (PubMed ID: 34287991)
1. Handgrip strength stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis.
Miwa T; Hanai T; Nishimura K; Maeda T; Ogiso Y; Imai K; Suetsugu A; Takai K; Shiraki M; Shimizu M
JPEN J Parenter Enteral Nutr; 2022 May; 46(4):858-866. PubMed ID: 34287991
[TBL] [Abstract][Full Text] [Related]
2. A simple covert hepatic encephalopathy screening model based on blood biochemical parameters in patients with cirrhosis.
Miwa T; Hanai T; Nishimura K; Maeda T; Tajirika S; Imai K; Suetsugu A; Takai K; Yamamoto M; Shimizu M
PLoS One; 2022; 17(11):e0277829. PubMed ID: 36449492
[TBL] [Abstract][Full Text] [Related]
3. A shortened Stroop test to identify covert hepatic encephalopathy and predict overt hepatic encephalopathy in patients with cirrhosis.
Hanai T; Nishimura K; Miwa T; Maeda T; Nakahata Y; Imai K; Suetsugu A; Takai K; Shimizu M
J Gastroenterol; 2022 Dec; 57(12):981-989. PubMed ID: 36173512
[TBL] [Abstract][Full Text] [Related]
4. Covert hepatic encephalopathy is associated with aggressive disease progression and poor survival in patients with cirrhosis.
Wang J; Deng MJ; Shi PM; Peng Y; Wang XH; Tan W; Wang PQ; Chen YX; Yuan ZL; Ning BF; Xie WF; Yin C
J Dig Dis; 2023 Dec; 24(12):681-690. PubMed ID: 38108656
[TBL] [Abstract][Full Text] [Related]
5. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization.
Patidar KR; Thacker LR; Wade JB; Sterling RK; Sanyal AJ; Siddiqui MS; Matherly SC; Stravitz RT; Puri P; Luketic VA; Fuchs M; White MB; Noble NA; Unser AB; Gilles H; Heuman DM; Bajaj JS
Am J Gastroenterol; 2014 Nov; 109(11):1757-63. PubMed ID: 25178701
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis.
Ballester MP; Tranah TH; Balcar L; Fiorillo A; Ampuero J; Kerbert AJC; Thomsen KL; Escudero MD; Mandorfer M; Reiberger T; Shawcross DL; Romero-Gómez M; Montoliu C; Carbonell-Asins JA; Jalan R
J Hepatol; 2023 Oct; 79(4):967-976. PubMed ID: 37277075
[TBL] [Abstract][Full Text] [Related]
7. Animal naming test is a simple and valid tool for detecting covert hepatic encephalopathy and predicting outcomes in Chinese-speaking regions: a preliminary study.
Huang CH; Yu TY; Tseng WJ; Huang YT; Chang SH; Hsieh SY; Chien RN; Amodio P
Ann Med; 2023 Dec; 55(1):2236013. PubMed ID: 37494454
[TBL] [Abstract][Full Text] [Related]
8. Zinc deficiency predicts overt hepatic encephalopathy and mortality in liver cirrhosis patients with minimal hepatic encephalopathy.
Miwa T; Hanai T; Toshihide M; Ogiso Y; Imai K; Suetsugu A; Takai K; Shiraki M; Katsumura N; Shimizu M
Hepatol Res; 2021 Jun; 51(6):662-673. PubMed ID: 33242359
[TBL] [Abstract][Full Text] [Related]
9. Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosis.
Labenz C; Nagel M; Toenges G; Kuchen R; Schattenberg JM; Hilscher M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
Eur J Intern Med; 2020 Dec; 82():83-89. PubMed ID: 32873457
[TBL] [Abstract][Full Text] [Related]
10. Covert hepatic encephalopathy and spontaneous portosystemic shunts increase the risk of developing overt hepatic encephalopathy.
Greinert R; Zipprich A; Simón-Talero M; Stangl F; Ludwig C; Wienke A; Praktiknjo M; Höhne K; Trebicka J; Genescà J; Ripoll C
Liver Int; 2020 Dec; 40(12):3093-3102. PubMed ID: 32890428
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis.
Gairing SJ; Danneberg S; Kaps L; Nagel M; Schleicher EM; Quack C; Engel S; Bittner S; Galle PR; Schattenberg JM; Wörns MA; Luessi F; Marquardt JU; Labenz C
JHEP Rep; 2023 Apr; 5(4):100671. PubMed ID: 36866390
[TBL] [Abstract][Full Text] [Related]
12. Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients.
Wang AJ; Peng AP; Li BM; Gan N; Pei L; Zheng XL; Hong JB; Xiao HY; Zhong JW; Zhu X
World J Gastroenterol; 2017 Sep; 23(34):6321-6329. PubMed ID: 28974899
[TBL] [Abstract][Full Text] [Related]
13. Higher scores in the Clinical Frailty Scale are associated with covert and overt hepatic encephalopathy in patients with cirrhosis.
Schleicher EM; Kaps L; Schattenberg JM; Galle PR; Wörns MA; Gairing SJ; Labenz C
Dig Liver Dis; 2024 Jun; 56(6):1046-1053. PubMed ID: 38105147
[TBL] [Abstract][Full Text] [Related]
14. Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival.
Gairing SJ; Mangini C; Zarantonello L; Gioia S; Nielsen EJ; Danneberg S; Lok AS; Sultanik P; Galle PR; Labenz J; Thabut D; Marquardt JU; Bloom PP; Lauridsen MM; Montagnese S; Nardelli S; Labenz C
J Intern Med; 2024 Mar; 295(3):331-345. PubMed ID: 37983845
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With Cirrhosis.
Labenz C; Toenges G; Huber Y; Nagel M; Marquardt JU; Schattenberg JM; Galle PR; Labenz J; Wörns MA
Am J Gastroenterol; 2019 May; 114(5):764-770. PubMed ID: 30848730
[TBL] [Abstract][Full Text] [Related]
16. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
[TBL] [Abstract][Full Text] [Related]
17. Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies.
Labenz C; Toenges G; Schattenberg JM; Nagel M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
Clin Transl Gastroenterol; 2020 Jun; 11(6):e00172. PubMed ID: 32568474
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing.
Duarte-Rojo A; Allampati S; Thacker LR; Flud CR; Patidar KR; White MB; Klair JS; Heuman DM; Wade JB; Gavis EA; Bajaj JS
Metab Brain Dis; 2019 Feb; 34(1):289-295. PubMed ID: 30506333
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients.
Nakai M; Suda G; Ogawa K; Yoshida S; Hosoda S; Kubo A; Tokuchi Y; Kitagataya T; Yamada R; Shigesawa T; Ohara M; Sho T; Morikawa K; Sakamoto N
PLoS One; 2022; 17(7):e0270786. PubMed ID: 35776720
[TBL] [Abstract][Full Text] [Related]
20. [Retrospective analysis of risk factors of liver cirrhosis combined with overt hepatic encephalopathy: a single -center case-control study].
Fan YN; Ji TT; Liang RY; Yu YY; Xu JH
Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):133-136. PubMed ID: 33685081
[No Abstract] [Full Text] [Related]
[Next] [New Search]
